US Stock MarketDetailed Quotes
ADPT Adaptive Biotechnologies
- 2.750
- +0.150+5.77%
Close Apr 29 16:00 ET
- 2.790
- +0.040+1.45%
Post 17:43 ET
405.26MMarket Cap-1762P/E (TTM)
2.800High2.620Low1.64MVolume2.620Open2.600Pre Close4.50MTurnover1.65%Turnover RatioLossP/E (Static)147.37MShares9.08052wk High1.31P/B272.52MFloat Cap2.28052wk Low--Dividend TTM99.10MShs Float71.250Historical High--Div YieldTTM6.92%Amplitude2.280Historical Low2.744Avg Price1Lot Size
Adaptive Biotechnologies Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 15.02%-156.32M | 10.28%-26.93M | -10.08%-46.68M | 49.95%-23.56M | 8.22%-59.15M | 4.56%-183.95M | 44.23%-30.02M | 2.38%-42.41M | -26.47%-47.07M | -10.66%-64.45M |
| Net income from continuing operations | -12.45%-225.3M | -72.94%-69.47M | -11.05%-50.33M | 8.20%-47.81M | 8.12%-57.7M | 3.34%-200.37M | 34.53%-40.17M | 19.07%-45.32M | -5.64%-52.08M | -54.51%-62.8M |
| Depreciation and amortization | 6.27%22.23M | 2.01%5.39M | 7.06%5.76M | 8.82%5.65M | 7.26%5.42M | 49.93%20.92M | 9.01%5.29M | 52.58%5.38M | 78.83%5.2M | 89.29%5.06M |
| Other non cash items | 51.25%12.39M | 1.68%2.17M | 49.80%3.71M | 68.83%3.05M | 95.15%3.46M | 17.88%8.19M | 25.71%2.14M | 40.16%2.48M | 2.67%1.81M | 2.84%1.77M |
| Change In working capital | 35.45%-46.18M | 66.50%-3.51M | 3.75%-18.65M | 102.30%449K | -10.21%-24.48M | -25.93%-71.55M | 13.86%-10.48M | -214.17%-19.37M | -230.72%-19.48M | 31.85%-22.21M |
| -Change in receivables | 108.97%2.03M | 49.91%-6.77M | 111.78%334K | 47.99%-621K | 277.82%9.09M | -207.63%-22.65M | -4,606.97%-13.51M | 3.80%-2.84M | -121.40%-1.19M | 47.37%-5.11M |
| -Change in inventory | -447.37%-2.84M | 31.30%3.98M | -479.17%-273K | 111.93%65K | -279.93%-6.61M | 115.71%817K | 393.51%3.03M | -81.10%72K | 54.20%-545K | 48.23%-1.74M |
| -Change in prepaid assets | -154.35%-1.93M | -31.05%2.03M | -9,969.77%-4.33M | 325.79%718K | -136.59%-352K | 176.13%3.55M | -16.31%2.95M | 98.98%-43K | -144.04%-318K | -24.43%962K |
| -Change in payables and accrued expense | -176.04%-5.41M | -49.30%5.34M | -150.71%-2.81M | 662.72%7.94M | -110.44%-15.88M | 80.48%7.11M | 767.30%10.53M | -30.74%5.54M | -129.51%-1.41M | -3.97%-7.55M |
| -Change in other working capital | 37.00%-38.04M | 39.95%-8.1M | 47.66%-11.57M | 52.21%-7.65M | -22.17%-10.72M | -22.02%-60.38M | -5.35%-13.48M | -200.34%-22.1M | -1.46%-16.02M | 35.17%-8.78M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 15.02%-156.32M | 10.28%-26.93M | -10.08%-46.68M | 49.95%-23.56M | 8.22%-59.15M | 4.56%-183.95M | 44.23%-30.02M | 2.38%-42.41M | -26.47%-47.07M | -10.66%-64.45M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 4,362.89%129.65M | 103.29%3.21M | -54.95%26.14M | 686.41%37.32M | 67.11%62.98M | -98.40%2.91M | -245.13%-97.54M | 372.78%58.02M | -88.55%4.75M | -59.83%37.69M |
| Net PPE purchase and sale | 34.57%-10.7M | 48.94%-1.3M | 48.86%-2.78M | 30.22%-3.7M | 4.97%-2.92M | 73.52%-16.35M | 72.50%-2.54M | 62.84%-5.43M | 75.96%-5.3M | 80.58%-3.08M |
| Net investment purchase and sale | 628.91%140.34M | 104.74%4.51M | -54.42%28.92M | 308.40%41.02M | 61.67%65.9M | -92.08%19.25M | -224.26%-95M | 1,054.23%63.45M | -84.18%10.04M | -62.83%40.77M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 4,362.89%129.65M | 103.29%3.21M | -54.95%26.14M | 686.41%37.32M | 67.11%62.98M | -98.40%2.91M | -245.13%-97.54M | 372.78%58.02M | -88.55%4.75M | -59.83%37.69M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -98.30%2.25M | 1,350.00%87K | -99.99%17K | -63.18%1.47M | -75.55%672K | 387.24%132.27M | -99.82%6K | 4,189.82%125.52M | -36.95%3.99M | -81.19%2.75M |
| Proceeds from stock option exercised by employees | -71.55%2.25M | -72.98%87K | -97.95%17K | -63.18%1.47M | -75.55%672K | -70.47%7.89M | -90.18%322K | -71.67%829K | -36.95%3.99M | -80.62%2.75M |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | 28,891.84%124.38M | ---316K | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -98.30%2.25M | 1,350.00%87K | -99.99%17K | -63.18%1.47M | -75.55%672K | 387.24%132.27M | -99.82%6K | 4,189.82%125.52M | -36.95%3.99M | -81.19%2.75M |
| Net cash flow | ||||||||||
| Beginning cash position | -34.54%92.43M | -58.35%91.63M | 42.23%112.16M | -17.29%96.93M | -34.54%92.43M | 12.45%141.2M | 76.64%219.99M | -57.68%78.86M | -33.33%117.19M | 12.45%141.2M |
| Current changes in cash | 49.91%-24.43M | 81.47%-23.64M | -114.55%-20.53M | 139.75%15.24M | 118.73%4.5M | -412.08%-48.78M | -865.46%-127.56M | 328.42%141.13M | -462.90%-38.33M | -147.85%-24.02M |
| End cash Position | -26.43%68M | -26.43%68M | -58.35%91.63M | 42.23%112.16M | -17.29%96.93M | -34.54%92.43M | -34.54%92.43M | 76.64%219.99M | -57.68%78.86M | -33.33%117.19M |
| Free cash flow | 16.61%-167.02M | 13.30%-28.23M | -3.39%-49.46M | 47.95%-27.25M | 8.08%-62.08M | 21.29%-200.29M | 48.37%-32.56M | 17.61%-47.84M | 11.63%-52.36M | 8.85%-67.53M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg